Cargando…
Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells
Claudin-1 (CLDN1), a tight junctional protein, is highly expressed in lung cancer cells and may contribute to chemoresistance. A drug which decreases CLDN1 expression could be a chemosensitizer for enhancing the efficacy of anticancer drugs, but there is no such drug known. We found that PMTPV, a sh...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460671/ https://www.ncbi.nlm.nih.gov/pubmed/32824620 http://dx.doi.org/10.3390/ijms21165909 |
_version_ | 1783576656378593280 |
---|---|
author | Nasako, Haruka Takashina, Yui Eguchi, Hiroaki Ito, Ayaka Ishikawa, Yoshinobu Matsunaga, Toshiyuki Endo, Satoshi Ikari, Akira |
author_facet | Nasako, Haruka Takashina, Yui Eguchi, Hiroaki Ito, Ayaka Ishikawa, Yoshinobu Matsunaga, Toshiyuki Endo, Satoshi Ikari, Akira |
author_sort | Nasako, Haruka |
collection | PubMed |
description | Claudin-1 (CLDN1), a tight junctional protein, is highly expressed in lung cancer cells and may contribute to chemoresistance. A drug which decreases CLDN1 expression could be a chemosensitizer for enhancing the efficacy of anticancer drugs, but there is no such drug known. We found that PMTPV, a short peptide, which mimics the structure of second extracellular loop (ECL2) of CLDN1, can reduce the protein level of CLDN1 without affecting the mRNA level in A549 cells derived from human lung adenocarcinoma. The PMTPV-induced decrease in CLDN1 expression was inhibited by monodansylcadaverine, a clathrin-mediated endocytosis inhibitor, and chloroquine, a lysosome inhibitor. Quartz crystal microbalance assay showed that PMTPV can directly bind to the ECL2 of CLDN1. In transwell assay, PMTPV increased fluxes of Lucifer yellow (LY), a paracellular flux marker, and doxorubicin (DXR), an anthracycline anticancer drug, without affecting transepithelial electrical resistance. In three-dimensional spheroid culture, the size and cell viability were unchanged by short peptides, but the fluorescence intensity of hypoxia probe LOX-1 was decreased by PMTPV. PMTPV elevated the accumulation and cytotoxicity of DXR in the spheroids. Similar results were observed by knockdown of CLDN1. Furthermore, the sensitivities to cisplatin (CDDP), docetaxel, and gefitinib were enhanced by PMTPV. The level of CLDN1 expression in CDDP-resistant cells was higher than that in parental A549 cells, which was reduced by PMTPV. PMTPV restored the toxicity to DXR in the CDDP-resistant cells. Our data suggest that PMTPV may become a novel chemosensitizer for lung adenocarcinoma. |
format | Online Article Text |
id | pubmed-7460671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74606712020-09-03 Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells Nasako, Haruka Takashina, Yui Eguchi, Hiroaki Ito, Ayaka Ishikawa, Yoshinobu Matsunaga, Toshiyuki Endo, Satoshi Ikari, Akira Int J Mol Sci Article Claudin-1 (CLDN1), a tight junctional protein, is highly expressed in lung cancer cells and may contribute to chemoresistance. A drug which decreases CLDN1 expression could be a chemosensitizer for enhancing the efficacy of anticancer drugs, but there is no such drug known. We found that PMTPV, a short peptide, which mimics the structure of second extracellular loop (ECL2) of CLDN1, can reduce the protein level of CLDN1 without affecting the mRNA level in A549 cells derived from human lung adenocarcinoma. The PMTPV-induced decrease in CLDN1 expression was inhibited by monodansylcadaverine, a clathrin-mediated endocytosis inhibitor, and chloroquine, a lysosome inhibitor. Quartz crystal microbalance assay showed that PMTPV can directly bind to the ECL2 of CLDN1. In transwell assay, PMTPV increased fluxes of Lucifer yellow (LY), a paracellular flux marker, and doxorubicin (DXR), an anthracycline anticancer drug, without affecting transepithelial electrical resistance. In three-dimensional spheroid culture, the size and cell viability were unchanged by short peptides, but the fluorescence intensity of hypoxia probe LOX-1 was decreased by PMTPV. PMTPV elevated the accumulation and cytotoxicity of DXR in the spheroids. Similar results were observed by knockdown of CLDN1. Furthermore, the sensitivities to cisplatin (CDDP), docetaxel, and gefitinib were enhanced by PMTPV. The level of CLDN1 expression in CDDP-resistant cells was higher than that in parental A549 cells, which was reduced by PMTPV. PMTPV restored the toxicity to DXR in the CDDP-resistant cells. Our data suggest that PMTPV may become a novel chemosensitizer for lung adenocarcinoma. MDPI 2020-08-17 /pmc/articles/PMC7460671/ /pubmed/32824620 http://dx.doi.org/10.3390/ijms21165909 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nasako, Haruka Takashina, Yui Eguchi, Hiroaki Ito, Ayaka Ishikawa, Yoshinobu Matsunaga, Toshiyuki Endo, Satoshi Ikari, Akira Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells |
title | Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells |
title_full | Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells |
title_fullStr | Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells |
title_full_unstemmed | Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells |
title_short | Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells |
title_sort | increase in toxicity of anticancer drugs by pmtpv, a claudin-1-binding peptide, mediated via down-regulation of claudin-1 in human lung adenocarcinoma a549 cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460671/ https://www.ncbi.nlm.nih.gov/pubmed/32824620 http://dx.doi.org/10.3390/ijms21165909 |
work_keys_str_mv | AT nasakoharuka increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT takashinayui increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT eguchihiroaki increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT itoayaka increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT ishikawayoshinobu increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT matsunagatoshiyuki increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT endosatoshi increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells AT ikariakira increaseintoxicityofanticancerdrugsbypmtpvaclaudin1bindingpeptidemediatedviadownregulationofclaudin1inhumanlungadenocarcinomaa549cells |